About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Bristol-Myers and Johnson & Johnson to Study Combination Therapy for Hepatitis C

by Dr. Trupti Shirole on December 4, 2011 at 5:03 PM
Font : A-A+

 Bristol-Myers and Johnson & Johnson to Study Combination Therapy for Hepatitis C

Bristol-Myers Squibb Co. will collaborate with a unit of Johnson & Johnson to study a potential combination therapy for chronic hepatitis C.

The companies will test the potentially positive effects of combining Johnson & Johnson's drug TMC435 with Bristol-Myers Squibb's daclatasvir. The clinical trials will begin in the first half of 2012 and will include a combination of the two drugs, the drugs plus pegylated interferon and ribavirin, and the drugs plus ribavirin.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Disability Day 2022 - The Role of Innovative Transformation
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Hepatitis A Hepatitis B Vasculitis Reiki and Pranic Healing Silent Killer Diseases Liver Aplastic Anemia Hepatitis C Combination Therapy for High Blood Pressure Hepatitis 

Most Popular on Medindia

Daily Calorie Requirements Nutam (400mg) (Piracetam) Drug Side Effects Calculator Noscaphene (Noscapine) The Essence of Yoga Indian Medical Journals Blood Pressure Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Diaphragmatic Hernia Post-Nasal Drip
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Bristol-Myers and Johnson & Johnson to Study Combination Therapy for Hepatitis C Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests